What Are the Worst Side Effects of Wegovy?

Pancreatitis is a rare but serious risk: severe stomach pain that spreads to the back warrants same-day medical attention, not a wait-and-see approach.
In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, if infrequent, side effect of GLP-1 medicines including semaglutide.
Most people's worst experience on Wegovy is nausea in the first few weeks after starting or after a dose increase, it usually settles as your body adjusts.
You can report any suspected side effect, or a suspicious seller, directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

The most serious side effects of Wegovy are acute pancreatitis, gallbladder problems, and severe dehydration from persistent vomiting or diarrhoea. These are uncommon but require urgent medical attention. The most frequent side effects are gastrointestinal — nausea, vomiting, constipation, diarrhoea — and most people experience them mildly, if at all, and they typically ease within days to a couple of weeks. Wegovy (semaglutide) is a prescription-only medicine, and a clinical assessment before you start it exists precisely so a prescriber can weigh these risks against your individual health picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The side effects that matter most, and how to tell them apart

Which Wegovy side effects are serious enough to call for urgent help?

A small number of side effects can become genuinely dangerous, and knowing the signals matters more than any list. The clearest one to understand is pancreatitis. In January 2026 the MHRA's Drug Safety Update on GLP-1 medicines drew attention to acute pancreatitis as an infrequent but potentially serious complication. The symptom to act on is severe, persistent stomach pain that spreads to the back, with or without vomiting. If that happens, stop eating and drinking and go to A&E or call 999; do not wait for it to pass on its own.

Gallbladder problems, including gallstones and gallbladder inflammation, are also documented. The warning signs are sharp pain in the upper right abdomen, sometimes with fever or yellowing of the skin. Again, these need prompt assessment.

Severe dehydration is a third category worth taking seriously. It's not caused by the medicine directly, but by prolonged vomiting or diarrhoea. Signs include dizziness when you stand, very dark urine, and a dry mouth that won't ease. If you can't keep fluids down for more than a day, seek medical advice rather than trying to push through. If you want a thorough overview before or during treatment, our page covering what are the side effects of Wegovy covers the complete picture of what to watch for across the whole treatment period.

What about the side effects most people actually notice week to week?

The commonest experience (the one our prescribers hear about most) is nausea, particularly in the first days after starting or moving up a dose. Constipation, loose stools, reflux, burping, and general stomach discomfort all appear in the trial data. Fatigue and mild headaches also show up, especially early on.

These effects are genuinely unpleasant for some people but are not medically dangerous in themselves. They tend to be worst when your body is adjusting to a new dose level, then gradually settle. A practical habit that helps many people: before you go to bed each night in the first two weeks of a new dose, run a quick mental check, how much did you drink today, and did you eat something small and bland with each meal? Hydration and small portions are the two levers you actually control, and consciously tracking them takes less than a minute.

The common side effects of Wegovy page goes into more detail on managing these day-to-day symptoms, and the NHS semaglutide page lists them alongside practical self-care steps.

Are there side effects that are rare but still worth knowing about?

Yes. Allergic reactions (rash, swelling of the face or throat, difficulty breathing) are uncommon but a reason to stop the medicine immediately and call 999. Thoughts of self-harm or low mood have been reported; the exact relationship to the medicine is still being studied, but if your mental state changes after starting Wegovy, tell your prescriber.

For people with diabetic eye disease, semaglutide has in some cases been linked to worsening of diabetic retinopathy, particularly early in treatment. This is mainly relevant in the diabetes context rather than weight management, but anyone with pre-existing eye disease should flag it at consultation.

Pulse rate increases by a few beats per minute on average, usually not significant, but worth monitoring if you have an underlying heart condition. The main side effects of Wegovy page addresses the full spectrum including these less-discussed effects. If any side effect concerns you, you can report it directly using the MHRA Yellow Card scheme, it's open to patients as well as healthcare professionals.

How does the timing of side effects change as treatment progresses?

The worst of the gastrointestinal side effects typically cluster around dose changes. Wegovy is titrated gradually (starting low and increasing every four weeks or so) and each step up can briefly revive symptoms you thought you'd already moved past. This is normal. It doesn't mean the medicine has stopped working; it means your body is re-adjusting.

By the time most people are on the maintenance dose, GI symptoms have reduced considerably for the majority. What sometimes replaces them are subtler things: changes in food preferences, a reduced interest in alcohol (reported anecdotally and in some studies), and for some, increased fatigue if dietary intake has dropped significantly. Our page on what side effects to expect from semaglutide explores how these patterns compare across people using the medicine for different purposes.

People who stop Wegovy abruptly sometimes experience rapid return of appetite. This isn't a side effect in the medical sense, but it's worth understanding before you decide to pause. If you're thinking about what comes next after treatment, the Wegovy overview covers the longer-term picture. And if you'd like to understand how semaglutide side effects change across the weeks and months, that page breaks down the timeline in detail. Our prescribers discuss all of this as part of the free consultation (including which side effects are most relevant to your own health history) if you'd like to check your eligibility.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions